Gilead Sciences, Inc.
General ticker "GILD" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $114.7B
Gilead Sciences, Inc. follows the US Stock Market performance with the rate: 31.8%.
Estimated limits based on current volatility of 1.1%: low 91.17$, high 93.28$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends: last record date 2024-12-13, amount 0.77$ (Y3.30%)
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [62.71$, 91.22$]
- 2024-12-30 to 2025-12-30 estimated range: [62.83$, 92.98$]
Financial Metrics affecting the GILD estimates:
- Positive: Operating profit margin, % of 28.05 > 19.51
- Positive: Return on assets ratio (scaled to [-100,100]) of 8.28 > 7.10
- Positive: -3.48 < Investing cash flow per share, $ of -1.81
- Positive: Non-GAAP EPS, $ of 6.72 > 2.29
- Negative: Interest expense per share, $ of 0.76 > 0.74
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term GILD quotes
Long-term GILD plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $27,305.00MM | $27,281.00MM | $27,116.00MM |
| Operating Expenses | $17,387.00MM | $19,951.00MM | $19,511.00MM |
| Operating Income | $9,918.00MM | $7,330.00MM | $7,605.00MM |
| Non-Operating Income | $-1,640.00MM | $-1,516.00MM | $-746.00MM |
| Interest Expense | $1,001.00MM | $935.00MM | $944.00MM |
| R&D Expense | $5,363.00MM | $4,977.00MM | $6,923.00MM |
| Income(Loss) | $8,278.00MM | $5,814.00MM | $6,859.00MM |
| Taxes | $2,077.00MM | $1,248.00MM | $1,247.00MM |
| Profit(Loss) | $6,201.00MM | $4,566.00MM | $5,612.00MM |
| Stockholders Equity | $21,064.00MM | $21,209.00MM | $22,833.00MM |
| Inventory | $2,734.00MM | $2,820.00MM | $1,787.00MM |
| Assets | $67,952.00MM | $63,171.00MM | $62,125.00MM |
| Operating Cash Flow | $11,384.00MM | $9,072.00MM | $8,006.00MM |
| Capital expenditure | $579.00MM | $728.00MM | $585.00MM |
| Investing Cash Flow | $-3,131.00MM | $-2,466.00MM | $-2,265.00MM |
| Financing Cash Flow | $-8,877.00MM | $-6,469.00MM | $-5,125.00MM |
| Earnings Per Share* | $4.96 | $3.66 | $4.54 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.